Anne Schuckman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An extended lymphadenectomy – removal of additional lymph nodes beyond the extent of the standard procedure – in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because of clinically localized muscle-invasive bladder cancer provides no patient benefit as measured by disease-free survival or overall survival times. It does, however, increase the risk of adverse events (side effects) and post-surgical death. These primary results from the phase 3 SWOG S1011 clinical trial are being delivered in an oral presentation at the 2023 annual meeting of the American Soc...

Clinical trial results established new treatment option that may offer patients better outcomes than traditional therapies

A newly published study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation.

Published 16 February 2021 (UroToday.com) The optimizing personalized management of non-muscle-invasive bladder cancer session at the 2021 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) included a presentation from Dr. Anne Schuckman discussing which patients with high-risk non-muscle-invasive bladder cancer may benefit from radical cystectomy. Dr. Shuckman notes that more than 70% of all newly diagnosed bladder cancers are non-muscle-invasive, including Ta (70%), T1 (20%), and CIS (10%). The natural history of non-muscle-invasive bladder cancer stratified ...